NY-ESO-1-Specific CD8 T Cell Response in NY-ESO-1 Seropositive Metastatic Melanoma Patients Treated with Ipilimumab Correlates with Clinical Benefit

被引：0
|
作者：
Yuan, Jianda [1 ]
Gnjatic, Sacha [2 ]
Adamow, Matthew [1 ]
Ginsberg, Brian [1 ]
Rasalan, Teresa S. [1 ]
Ritter, Erika [2 ]
Gallardo, Humilidad F. [1 ]
Xu, Yinyan [1 ]
Pogoriler, Evelina [3 ]
Panageas, Katherine S. [3 ]
Yang, Arvin [1 ,3 ]
Terzulli, Stephanie [1 ,3 ]
Ritter, Gerd [2 ]
Old, Lloyd J. [2 ]
Allison, James P. [1 ]
Wolchok, Jedd D. [1 ,3 ]
机构：
[1] Ludwig Ctr Canc Immunotherapy, New York, NY USA
[2] Ludwig Inst Canc Res, NY Branch, New York, NY USA
[3] MSKCC, New York, NY USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2010年 / 33卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：913 / 914
页数：2
相关论文
共 50 条
  • [31] Generation of induced pluripotent stem cells (iPSCs) from NY-ESO-1-specific CD8+T cell isolated from the patient with melanoma
    Itoh, M.
    Kawagoe, S.
    Okano, H. J.
    Nakagawa, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S231 - S231
  • [32] A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients
    Ayyoub, M
    Souleimanian, NE
    Godefroy, E
    Scotto, L
    Hesdorffer, CS
    Old, LJ
    Valmori, D
    CLINICAL IMMUNOLOGY, 2006, 118 (2-3) : 188 - 194
  • [33] Primary human lymphocytes retrovirally transduced with NY-ESO-1 antigen specific TCR genes recognize and kill NY-ESO-1 positive melanoma as well as other tumors.
    Zhao, YB
    Zheng, ZL
    Robbins, PF
    Khong, HT
    Rosenberg, SA
    Morgan, RA
    BLOOD, 2003, 102 (11) : 746A - 746A
  • [34] A Novel Murine T-Cell Receptor Targeting NY-ESO-1
    Rosati, Shannon F.
    Parkhurst, Maria R.
    Hong, Young
    Zheng, Zhili
    Feldman, Steven A.
    Rao, Mahadev
    Abate-Daga, Daniel
    Beard, Rachel E.
    Xu, Hui
    Black, Mary A.
    Robbins, Paul F.
    Schrump, David A.
    Rosenberg, Steven A.
    Morgan, Richard A.
    JOURNAL OF IMMUNOTHERAPY, 2014, 37 (03) : 135 - 146
  • [35] Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules
    Bethune, Michael T.
    Li, Xiao-Hua
    Yu, Jiaji
    McLaughlin, Jami
    Cheng, Donghui
    Mathis, Colleen
    Moreno, Blanca Homet
    Woods, Katherine
    Knights, Ashley J.
    Garcia-Diaz, Angel
    Wong, Stephanie
    Hu-Lieskovan, Siwen
    Puig-Saus, Cristina
    Cebon, Jonathan
    Ribas, Antoni
    Yang, Lili
    Witte, Owen N.
    Baltimore, David
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (45) : E10702 - E10711
  • [36] DECITABINE PRIMES GLIOBLASTOMA TO NY-ESO-1 SPECIFIC T-CELL CYTOLYSIS VIA DNA DEMETHYLATION OF NY-ESO-1, CANCER-TESTIS ANTIGENS, AND PRO-INFLAMMATORY SIGNATURES
    Lai, Thomas
    Sun, Lu
    Treger, Janet
    Li, Tie
    Li, Kevin
    Prins, Terry
    Lai, Albert
    Prins, Robert
    Everson, Richard
    NEURO-ONCOLOGY, 2023, 25
  • [37] Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+T Cells in Cutaneous Melanoma
    Giavina-Bianchi, Mara
    Giavina-Bianchi, Pedro
    Sotto, Mirian Nacagami
    Muzikansky, Alona
    Kalil, Jorge
    Festa-Neto, Cyro
    Duncan, Lyn M.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [38] BIOMARKER CORRELATES OF RESPONSE IN PATIENTS WITH ADVANCED MYXOID/ROUND CELL LIPOSARCOMA (MRCLS) TREATED WITH NY-ESO-1 TCR T CELLS (LETETRESGENE AUTOLEUCEL)
    Kapoor, Gurpreet
    Zajic, Stefan
    Suchindran, Sunil
    Kim, Jaegil
    Eleftheriadou, Ioanna
    Huff, Anne
    Nathenson, Michael
    Druta, Mihaela
    Van Tine, Brian
    Somaiah, Neeta
    Liebner, David
    Schuetze, Scott
    D'Angelo, Sandra
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A424 - A424
  • [39] CD8+ T-cell response to NY-ESO-1:: Relative antigenicity and in vitro immunogenicity of natural and analogue sequences
    Romero, P
    Dutoit, V
    Rubio-Godoy, V
    Liénard, D
    Speiser, D
    Guillaume, P
    Servis, K
    Rimoldi, D
    Cerottini, JC
    Valmori, D
    CLINICAL CANCER RESEARCH, 2001, 7 (03) : 766S - 772S
  • [40] CD8α-Enhanced NY-ESO-1-Specific TCR T Cells (GSK3901961) in HLA-A*02 Patients with NSCLC: Master Protocol Substudy 1
    Altan, M.
    Govindan, R.
    Schoenfeld, A.
    Noujaim, J.
    Sacher, A.
    Haanen, J.
    Huang, C.
    Hasan, A.
    Faitg, T.
    Butler, E.
    Shalabi, A.
    Owonikoko, T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S337 - S338
12345